BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36476259)

  • 1. Alpha-actnin-4 (ACTN4) selectively affects the DNA double-strand breaks repair in non-small lung carcinoma cells.
    Kriger D; Novitskaya K; Vasileva G; Lomert E; Aksenov ND; Barlev NA; Tentler D
    Biol Direct; 2022 Dec; 17(1):40. PubMed ID: 36476259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of FGFR2-Signaling Attenuates a Homology-Mediated DNA Repair in GIST and Sensitizes Them to DNA-Topoisomerase II Inhibitors.
    Sergei B; Pavel D; Aigul G; Firyuza B; Ilmira N; Ilshat M; Aida A; Refat K; Natalia A; Elena S; Vera G
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting MALAT1 induces DNA damage and sensitize non-small cell lung cancer cells to cisplatin by repressing BRCA1.
    Huang J; Lin C; Dong H; Piao Z; Jin C; Han H; Jin D
    Cancer Chemother Pharmacol; 2020 Nov; 86(5):663-672. PubMed ID: 33030583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells.
    Kopa P; Macieja A; Pastwa E; Majsterek I; Poplawski T
    Mol Biol Rep; 2021 Jan; 48(1):709-720. PubMed ID: 33389482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP14 Regulates DNA Damage Response and Is a Target for Radiosensitization in Non-Small Cell Lung Cancer.
    Sharma A; Almasan A
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53-53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure.
    Pustovalova M; Alhaddad L; Smetanina N; Chigasova A; Blokhina T; Chuprov-Netochin R; Osipov AN; Leonov S
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitors.
    Binaschi M; Capranico G; De Isabella P; Mariani M; Supino R; Tinelli S; Zunino F
    Int J Cancer; 1990 Feb; 45(2):347-52. PubMed ID: 2154411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells.
    Chen P; Li J; Chen YC; Qian H; Chen YJ; Su JY; Wu M; Lan T
    Cell Oncol (Dordr); 2016 Dec; 39(6):511-522. PubMed ID: 27473273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-actinin 4 is associated with cancer cell motility and is a potential biomarker in non-small cell lung cancer.
    Wang MC; Chang YH; Wu CC; Tyan YC; Chang HC; Goan YG; Lai WW; Cheng PN; Liao PC
    J Thorac Oncol; 2015 Feb; 10(2):286-301. PubMed ID: 25299231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of RelA/p65 and ACTN4 induces apoptosis in non-small lung carcinoma cells.
    Lomert E; Turoverova L; Kriger D; Aksenov ND; Nikotina AD; Petukhov A; Mittenberg AG; Panyushev NV; Khotin M; Volkov K; Barlev NA; Tentler D
    Cell Cycle; 2018; 17(5):616-626. PubMed ID: 29251177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficiency of homologous recombination and non-homologous end joining systems in repairing double-strand breaks during cell cycle progression.
    Bee L; Fabris S; Cherubini R; Mognato M; Celotti L
    PLoS One; 2013; 8(7):e69061. PubMed ID: 23874869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional validation of miRNAs targeting genes of DNA double-strand break repair to radiosensitize non-small lung cancer cells.
    Piotto C; Biscontin A; Millino C; Mognato M
    Biochim Biophys Acta Gene Regul Mech; 2018 Dec; 1861(12):1102-1118. PubMed ID: 30389599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of DNA repair in the absence of classical non-homologous end joining.
    Kang YJ; Yan CT
    DNA Repair (Amst); 2018 Aug; 68():34-40. PubMed ID: 29929045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines.
    Kasahara K; Fujiwara Y; Sugimoto Y; Nishio K; Tamura T; Matsuda T; Saijo N
    J Natl Cancer Inst; 1992 Jan; 84(2):113-8. PubMed ID: 1310509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer.
    Sriramareddy SN; Jamakhani M; Vilanova L; Brossel H; Staumont B; Hamaidia M
    Front Oncol; 2024; 14():1323313. PubMed ID: 38380364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase II-mediated DNA damage is differently repaired during the cell cycle by non-homologous end joining and homologous recombination.
    de Campos-Nebel M; Larripa I; González-Cid M
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles for 53BP1 in the repair of radiation-induced DNA double strand breaks.
    Shibata A; Jeggo PA
    DNA Repair (Amst); 2020 Sep; 93():102915. PubMed ID: 33087281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.
    Pustovalova M; Alhaddad L; Blokhina T; Smetanina N; Chigasova A; Chuprov-Netochin R; Eremin P; Gilmutdinova I; Osipov AN; Leonov S
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells.
    Gao Y; Kardos J; Yang Y; Tamir TY; Mutter-Rottmayer E; Weissman B; Major MB; Kim WY; Vaziri C
    Sci Rep; 2018 Oct; 8(1):15304. PubMed ID: 30333500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4.
    Miura N; Kamita M; Kakuya T; Fujiwara Y; Tsuta K; Shiraishi H; Takeshita F; Ochiya T; Shoji H; Huang W; Ohe Y; Yamada T; Honda K
    Oncotarget; 2016 May; 7(22):33165-78. PubMed ID: 27121206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.